DK1819320T3 - Oralt dispergerbar farmaceutisk sammensætning og fremgangsmåde til fremstilling heraf - Google Patents

Oralt dispergerbar farmaceutisk sammensætning og fremgangsmåde til fremstilling heraf

Info

Publication number
DK1819320T3
DK1819320T3 DK05817592T DK05817592T DK1819320T3 DK 1819320 T3 DK1819320 T3 DK 1819320T3 DK 05817592 T DK05817592 T DK 05817592T DK 05817592 T DK05817592 T DK 05817592T DK 1819320 T3 DK1819320 T3 DK 1819320T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical composition
orally dispersible
dispersible pharmaceutical
orally
Prior art date
Application number
DK05817592T
Other languages
Danish (da)
English (en)
Inventor
Leonardo Marchitto
Lorella Ragni
Luca Donati
Mauro Valenti
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Application granted granted Critical
Publication of DK1819320T3 publication Critical patent/DK1819320T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK05817592T 2004-12-10 2005-11-25 Oralt dispergerbar farmaceutisk sammensætning og fremgangsmåde til fremstilling heraf DK1819320T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002356A ITMI20042356A1 (it) 2004-12-10 2004-12-10 Composizione farmaceutica orodisperdibile e procedimento per prepararla
PCT/EP2005/012859 WO2006061142A1 (en) 2004-12-10 2005-11-25 Orally dispersible pharmaceutical composition and process for the preparation thereof

Publications (1)

Publication Number Publication Date
DK1819320T3 true DK1819320T3 (da) 2009-01-12

Family

ID=34956709

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05817592T DK1819320T3 (da) 2004-12-10 2005-11-25 Oralt dispergerbar farmaceutisk sammensætning og fremgangsmåde til fremstilling heraf

Country Status (24)

Country Link
US (1) US20090074867A1 (de)
EP (1) EP1819320B1 (de)
JP (1) JP4980926B2 (de)
KR (1) KR101249855B1 (de)
CN (1) CN101065113B (de)
AR (1) AR052149A1 (de)
AT (1) ATE409463T1 (de)
AU (1) AU2005313588B2 (de)
BR (1) BRPI0518847A2 (de)
CA (1) CA2585940C (de)
DE (1) DE602005010115D1 (de)
DK (1) DK1819320T3 (de)
EA (1) EA010587B1 (de)
ES (1) ES2314742T3 (de)
GE (1) GEP20094589B (de)
HK (1) HK1105872A1 (de)
IL (1) IL182865A (de)
IT (1) ITMI20042356A1 (de)
MX (1) MX2007006705A (de)
PL (1) PL1819320T3 (de)
PT (1) PT1819320E (de)
SI (1) SI1819320T1 (de)
UA (1) UA89656C2 (de)
WO (1) WO2006061142A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20061883A1 (it) * 2006-09-29 2008-03-30 Monteres S R L Formulazioni orodispersibili, gastroprotettive e taste- masking contenenti almeno un principio attivo gastrolesivo
DK2240154T3 (da) * 2008-02-01 2014-07-21 Acraf Kosmetisk sammensætning omfattende glycogentil anvendelse med fløjlsblød virkning
US9125823B2 (en) * 2009-01-23 2015-09-08 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Controlled release pharmaceutical or food formulation and process for its preparation
SG178069A1 (en) 2009-08-03 2012-03-29 Acraf Food formulation comprising glycogen
EP2316433A1 (de) * 2009-10-22 2011-05-04 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Flurbiprofen Tabletten
DK2833880T3 (en) * 2012-04-02 2017-12-04 Pharma Seeds Create Llc Oral solid dosage composition with ibuprofen comprising a methacrylic acid copolymer

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1214629B (it) * 1985-08-29 1990-01-18 Formenti Farmaceutici Spa Procedimento di microincapsulazione di un medicamento,medicamento cosi'preparato,e composizioni farmaceutiche che lo comprendono
DE3730533A1 (de) * 1987-09-11 1989-03-30 Biotest Pharma Gmbh Verfahren zur sterilisation von plasma oder plasmafraktionen
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
JPH02282323A (ja) * 1989-04-21 1990-11-19 Shin Etsu Chem Co Ltd 徐放性錠剤の製造方法
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
CA2063141C (en) * 1989-08-04 1997-03-04 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
NZ234587A (en) * 1989-08-04 1991-11-26 Mcneil Ppc Inc A chewable pharmaceutical tablet of compressed coated granules
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5405617A (en) * 1991-11-07 1995-04-11 Mcneil-Ppc, Inc. Aliphatic or fatty acid esters as a solventless carrier for pharmaceuticals
HU219349B (en) * 1991-12-24 2001-03-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation and production thereof
JP3069458B2 (ja) * 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
US5837277A (en) * 1992-06-04 1998-11-17 Smithkline Beecham Corporation Palatable pharmaceutical compositions
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5728403A (en) * 1994-10-05 1998-03-17 The Board Of Regents Of The University Of Nebraska Coating technology for taste masking orally administered bitter drugs
CA2134611C (en) * 1994-10-28 2002-12-24 Richard John Yarwood Process for preparing solid pharmaceutical dosage forms
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
BR9711585A (pt) * 1996-10-01 2000-01-18 Cima Labs Inc Composição de microcápsula, com sabor mascarado, de um remédio solúvel em água, formulação farmacêutica para administrar um remédio, e, processo para disfarçar o sabor de um remédio.
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
AR014133A1 (es) * 1997-12-19 2001-02-07 Smithkline Beecham Corp Procedimiento para fabricar tabletas de dispersion rapida para administracion oral y una formulacion de dichas tabletas
KR20010041609A (ko) * 1998-03-06 2001-05-25 유란드 인터내셔날 에스.피.아. 속해성 정제
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles

Also Published As

Publication number Publication date
AU2005313588A1 (en) 2006-06-15
EA010587B1 (ru) 2008-10-30
US20090074867A1 (en) 2009-03-19
BRPI0518847A2 (pt) 2008-12-09
SI1819320T1 (sl) 2009-02-28
ATE409463T1 (de) 2008-10-15
PT1819320E (pt) 2008-11-20
CN101065113B (zh) 2012-04-11
JP4980926B2 (ja) 2012-07-18
JP2008522995A (ja) 2008-07-03
CA2585940C (en) 2012-09-25
CA2585940A1 (en) 2006-06-15
IL182865A (en) 2010-06-30
AR052149A1 (es) 2007-03-07
UA89656C2 (ru) 2010-02-25
DE602005010115D1 (de) 2008-11-13
AU2005313588B2 (en) 2012-05-24
EP1819320A1 (de) 2007-08-22
EP1819320B1 (de) 2008-10-01
KR101249855B1 (ko) 2013-04-05
HK1105872A1 (en) 2008-02-29
CN101065113A (zh) 2007-10-31
IL182865A0 (en) 2007-08-19
GEP20094589B (en) 2009-01-12
MX2007006705A (es) 2007-10-08
ES2314742T3 (es) 2009-03-16
ITMI20042356A1 (it) 2005-03-10
PL1819320T3 (pl) 2009-03-31
EA200700877A1 (ru) 2007-10-26
WO2006061142A1 (en) 2006-06-15
KR20070085941A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
AP2008004447A0 (en) Orally absorbed pharmaceutical formulation and method of administration
DK1862158T3 (da) Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf
DK1924577T3 (da) Substituerede benzimidazoler og fremgangsmåder til fremstilling
DK1940364T3 (da) Kapselformulering af pirfenidon og farmaceutisk acceptable excipienser
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK2298288T4 (da) Overtrukket tabletformulering og fremgangsmåde
DK1534237T3 (da) Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf
DK1490062T3 (da) Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf
DK1913001T3 (da) (r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf
DK1896364T3 (da) Pulverformet kalksammensætning, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1874557T3 (da) Identitetsdokument og fremgangsmåde til fremstilling deraf
DK1909764T3 (da) Farmaceutisk sammensætninger omfattende levetiracetam og fremgangsmåde til deres fremstilling
DK1673349T3 (da) Benzimidazolderivater: fremstilling og farmaceutiske anvendelser
DK1771201T3 (da) Sammensætninger og fremgangsmåder til behandling eller forebyggelse af oxalat-relateret sygdom
DK2056964T3 (da) Hidtil ukendt molekylsigtesammensætning, fremgangsmåde til fremstilling deraf og fremgangsmåde til anvendelse deraf
IS2708B (is) Aðferð til að meðhöndla hnútahersli, blóðfituröskun og tengdar ástandstegundir og lyfjasamsetningar
DK1948695T3 (da) Immunogene sammensætninger og fremgangsmåder til andvendelse
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DK1715893T3 (da) Direkte kompressionsformulering og fremgangsmåde
DK1824775T3 (da) Debrideringssammensætning baseret på bromelain og fremgangsmåder til fremstilling deraf
NO20055652D0 (no) Laktatinneholdende farmasoytisk preparat og anvendelse av dette
EP1838291A4 (de) Pharmazeutische formulierungen und verwendungsverfahren dafür
DK1968990T3 (da) Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
DK1817055T3 (da) Ovr110-antistofsammensætninger og fremgangsmåder til anvendelse heraf
DK1819320T3 (da) Oralt dispergerbar farmaceutisk sammensætning og fremgangsmåde til fremstilling heraf